Open for inclusion

A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride Versus Placebo When Administered to Metastatic HER2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases Treated With Hormonal Treatment Backg

Cancer type: Breast cancer

Phase: II

Principal Investigator: Danø Hella

Country: DK

Keywords: Denmark, Herlev, breast cancer

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02258464?term=02258464&rank=1